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Abstract
Porous ceramic scaffolds are widely studied in the tissue engineering field due to their potential in medical applications as
bone substitutes or as bone-filling materials. Solid free form (SFF) fabrication methods allow fabrication of ceramic scaffolds
with fully controlled pore architecture, which opens new perspectives in bone tissue regeneration materials. However, little
experimentation has been performed about real biological properties and possible applications of SFF designed 3D ceramic
scaffolds. Thus, here the biological properties of a specific SFF scaffold are evaluated first, both in vitro and in vivo, and later
scaffolds are also implanted in pig maxillary defect, which is a model for a possible application in maxillofacial surgery. In
vitro results show good biocompatibility of the scaffolds, promoting cell ingrowth. In vivo results indicate that material on its
own conducts surrounding tissue and allow cell ingrowth, thanks to the designed pore size. Additional osteoinductive
properties were obtained with BMP-2, which was loaded on scaffolds, and optimal bone formation was observed in pig
implantation model. Collectively, data show that SFF scaffolds have real application possibilities for bone tissue engineering
purposes, with the main advantage of being fully customizable 3D structures.
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Introduction
Porous bioceramics are widely used in medical applications as
bone substitutes or as bone-filling materials [1–4]. These porous
scaffolds are used to provide structural support and also to serve as
a template for cell colonization and extracellular matrix formation
[5]. Both degradable and non-degradable ceramics are used to
fabricate scaffolds and also multiple methods have been used to
create the porous structure [6–8].
However, most conventional scaffold fabrication methods do
not allow the fabrication of structures with customized and
complex external shapes or internal pore architectures. Solid free
form (SFF) fabrication techniques - three-dimensional printing,
stereolithography, fused deposition modeling, robocasting, phase-
change jet printing, etc. - constitute an excellent alternative to
produce well-defined 3D structures [9–13]. These SFF technolo-
gies involve building 3-D objects from a computer-aided design
(CAD) model using layered manufacturing strategies. An addi-
tional advantage of SFF scaffolds is that potentially they could be
specifically designed for specific bone defects, for example, taking
as model an x-ray tomography image.
Robocasting, also known as direct-write assembly or micro-
robotic deposition, is a SFF method that consists of the robotic
deposition of water-based colloidal suspensions (inks), with a high
solid-load and a minimal organic content (,1 wt.%), capable of
fully supporting their own weight during assembly [14,15].
Deposition is usually made within an oil bath to prevent non
uniform drying during assembly. Thus, a 3D network of semisolid
ink rods is created layer-by-layer without the need for a sacrificial
support material or mould.
Recent work has been directed towards developing ceramic
robocast structures [16–18] with the aim of combining the
excellent biological properties of the bioceramics with those
provided by a fully controlled, reproducible and customizable
architecture. Extensive material characterization has been per-
formed in order to elucidate the mechanical properties of these
PLoS ONE | www.plosone.org 1 March 2012 | Volume 7 | Issue 3 | e34117scaffolds [16,17,19,20]. However, as yet, there is no biological
information available to confirm the expected applicability of free
form designed, architecturally well-defined ceramics.
In vitro biological properties [21–23] and prospective in vivo
assays [12,24–28] are already performed with other SFF designed
scaffolds, which were made of different materials as polymers,
composites and ceramics. Thus, the purpose of this work is
biological and it is related firstly to testing the biocompatibility and
bioactivity of these scaffolds, and later to assess the potential of this
approach to become clinically viable. In addition, the benefits of
incorporate an osteoinductive factor in the robocast scaffolds are
also explored in this work. BMP-2 is a well-known osteoinductive
growth factor that combined with porous ceramics improves the
osteointegration [29–32].
Results and Discussion
1. Scaffold presentation and morphology
Material fabrication process and physical properties have been
previously described [16,17,19,20]. It is well known the impor-
tance of some scaffold properties in tissue conduction processes
[33,34]. Features like scaffold geometry and surface properties are
biologically relevant, since they have a strong influence in cell
adhesion and proliferation processes [35,36]. For testing assays
square scaffolds were designed. Structural data are summarized on
figure 1 (see table) and macrostructure is also shown in Figure 1,
imaged by SEM (fig. 1A) and mCT (fig. 1B). Views of the entire
scaffolds (fig. 1A1, 1B1), top surface (fig. 1A2, 1B2) and transversal
section (Fig. 1A3, 1B3) are presented. Images correspond to
different samples.
2. In vitro testing
Cellular assays were performed in order to assess cell adhesion,
viability, proliferation and migration on mentioned scaffolds. For
these assays C2C12 pre-myoblastic cell line was selected. As
adherent cell line, it allows testing cell adhesion and colonization
of scaffold surfaces. In addition, C2C12 cell line has the ability to
evolve to an osteoblastic phenotype upon the addition of BMP-2
[37–41]. BMP-2 modifies multiple cellular processes in C2C12
cells, as cell adhesion, proliferation and migration, thereby
inducing osteodifferentiation and processes implicated in new
bone tissue vascularization and progression [40–42].
Thus, firstly cell adhesion and spreading was checked. Figure 2
shows micrographs of different methods used to visualize cells on
scaffolds surface. The green fluorescence observed on Fig. 2A1
and 2A2 corresponds to calcein vital staining, and shows viable
cells adhered on the scaffold surface. A comparison of fluorescent
(Fig. 2A2) and white light (Fig. 2A3) images shows that adhered
cells tend to follow the material surface pattern. Further evidence
of this is shown in the SEM images (Fig. 2B); On the unseeded
scaffold (Fig. 2B1) a pattern of extrusion marks is evident on the
material’s rod surfaces, while the image of a fully cell-covered
scaffold (Fig. 2B2) shows the tendency of cells to follow the
scaffold’s irregular, grooved surface. Also cell nucleous and actin
cytoskeleton were stained and visualized in a confocal microscope
(Fig. 2C: blue, nucleous; red, actin cytoskeleton). Images show
again a fully cell-covered scaffold surface, assessing the ability of
the scaffolds to promote cell adhesion and growth.
Figure 2 demonstrates good cell adhesion and spreading on the
material surface, and suggests an influence of the scaffold surface
patterning on the cell distribution and shape. However, a critical
feature in porous scaffolds is the capability for seeded cells to
migrate and grow on the inner surfaces. Figure 2 shows partially
cells penetrating inside scaffolds but microscopic techniques are
not enough to assess it. Thus, histological and MRI assays were
performed in order to observe cells deep inside structure. Figure 3A
shows in black the area in which these assays were performed.
Histology is already used for other 3D material testing [21].
Figure 3B corresponds to a histological slice obtained in the center
of the specimen and it shows cells inner scaffold’s structure. MRI
technique was also used to see/check live cells inner scaffold
structure. Figure 3C1 shows a non cell-seeded material while
figure 3C2 shows a cell seeded scaffold. There bright areas in the
porous structure correspond to live cells. Additionally, 3D MRI
studies were performed and cells were located in entire scaffold
structure (see Movie S1).
All previous results show cells in the surface or inside material
structure, but cell proliferation should be assessed in order to
consider a material biocompatible. The proliferation of cells was
quantified using two complementary methods, which are MTS
and alamar blue tests. The time course plot of these assays (Fig. 3D)
shows the cell proliferation behavior in the scaffold. As it can be
observed, initially ,10000 cells adhered to the scaffold, while
subsequent measurements show good cell proliferation on the
material. Doubling time of cells on scaffolds was estimated in
32,1 hours, which is similar to the doubling time of C2C12 cells in
control plastic cell culture surface (29,7 hours).
Figure 1. SFF designed Scaffold. A) SEM micrographs of scaffold samples. A1) Entire scaffolds; A2) top plane view; A3) cross-section view. B) mCT
images of scaffold samples. B1) Entire scaffolds; B2) top plane view; B3) cross-section view. Table shows measured structural data.
doi:10.1371/journal.pone.0034117.g001
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included to scaffolds, via factor-adsorption onto the surface or via
factor-entrapping in a carrier material [43–46]. BMP-2 is a well
known osteoinductive factor [30,31,41,47–49] and this property is
desirable if in vivo bone formation is desired. Here we selected and
tested two delivery methods which have been previously reported,
both in vitro and in vivo, with BMP-2 and other scaffolds: 1- surface
adsorption [32,50], which is later in vivo assayed in models 3.1 and
3.2, and 2- entrapping in a coating material (Chitosan) [40–42]
which is later shown in in vivo model 3.3. These methods were
selected because there are several paper focused on BMP2
adsorption on ceramic scaffolds and subsequent delivery and also
because we previously reported BMP-2 delivery from chitosan
coating [42].
The activity of this growth factor on the scaffold surface was in
vitro assessed by measuring the ALP activity (an osteoblastic
differentiation specific marker) of scaffold-adhered cells after the
first, fifth and ninth culture day. Plot in Fig. 4C shows that ALP
activity appears at fifth culture day and grows at ninth when BMP-
2 is present on scaffold. These data indicate that BMP-2 on
scaffolds is active and induces in vitro bone differentiation. In
contrast, cells seeded on the control scaffolds do not present ALP
activity in any case.
All together, in vitro results show that these scaffolds are
adequate for cell attachment, proliferation and colonization of
entire structure, thereby confirming that these SFF-designed
materials have appropriate biological properties, at least in vitro.
3. In vivo assays
Bone tissue regeneration is the main applicability of ceramic
scaffolds. However, in scaffold field, a gap exists between research
and clinical translation [51–55]. Thus, focused on a translational
approach, we decided to perform an exhaustive in vivo testing, both
in small and large animal models, both in ectopic and orthotopic
models, and also both in delayed bone healing model and critical
size bone defects, in order to verify material properties. Thus,
assays were designed in order to firstly check the conductive effect
of the control scaffolds and later confirm osteoinductive property
of scaffold/BMP-2 samples.
3.1. Rabbit: Muscle Implantation. Initially biological
behavior of scaffolds was tested by implantation of samples in
rabbit dorsal muscle tissue. This ectopic model allows the testing of
both conductive effect of scaffold’s structure and osteoinductive
effect of incorporated BMP-2. Fig. 5 shows histological appearance
of samples implanted during 3 weeks. Control scaffolds
(Figures 5A) show a matrix filled of muscle tissue which comes
from the surrounding to inside material. Also fibrous tissue can be
observed. On the other hand, scaffolds with BMP-2 exhibit a cell
invaded matrix (Fig. 5B), but the appearance is completely
different. In these cases, fatty tissue with vessels containing red
blood cells can be observed between large areas of newly formed
Figure 2. Cell adhesion studies. A) Calcein cell viability assay. A1) Fluorescence image of a cell-seeded scaffold after 3 days. Green cells are viable
cells. A2) A detailed image showing green viable cells adhered to the material. A3) Light image of the same sample area. Arrows in A2 and A3 mark
similarities between surface morphology and cellular pattern. B) SEM images. B1) Image of a control, unseeded scaffold. Arrows indicate extrusion
marks in the surface of the ceramic rods. B2) A cell seeded scaffold after 7 days. Note that cells follow the pattern of the surface morphology indicated
in B1 image. C) Confocal image of a cell covered scaffold surface at seventh culture day. (Red, actin cytoskeleton; Blue, Nucleous).
doi:10.1371/journal.pone.0034117.g002
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formation inside the material with generation of fatty marrow
spaces.
These results show that the macropore structure allows
surrounding tissue colonize inner space of robocast scaffold.
However, the influence of the BMP-2 in the newly formed tissue
was remarkable (Fig. 5): muscle tissue and fibrous tissue were
observed inside the control scaffolds, while ectopic bone tissue was
formed inside BMP-2 activated scaffolds. This bone formation
associated with marrow suggests that BMP-2 and scaffold structure
allow a direct bone-inducing effect [43,44].
3.2. Rabbit: Bone Implantation. These findings were
confirmed in a second in vivo model in an orthotopic location. In
this case, bone defects were created in rabbit tibia and samples
were implanted (fig. 6). Figure 6 shows surgery procedure and
sample appearance 3 weeks after surgery. Control samples were
stable in the bone tissue and look integrated, while BMP-2 samples
show high amount of bone formation onto and around the
implanted material. The representative mCT slides in Figure 6
show no bone around the control scaffolds (fig. 6A2) while newly
formed bone is clearly observable surrounding the BMP-2 carrier
scaffolds (fig. 6B2). Furthermore, the histological study shows that
fibrous tissue was formed deep inside control implanted scaffolds
Figure 3. Inner-cells studies and quantification assays. A) Scheme of cell-location studies. Black area correspond to studied area. B) Histology
inner the robocasting structure. Asterisks show the location of ceramic rods, which are empty spaces due to performed sample decalcification. Note
C2C12 cells located in entire scaffold structure. C) Non-destructive MRI images obtained inner scaffold structure. C1) Non cell-seeded scaffold C2) Cell
seeded scaffold. Note brightness in most porous structure attributable to cell presence. D) Quantitative assays for cell proliferation measurement.
Graphic represents the time course plot obtained in both MTS and Alamar Blue assays.
doi:10.1371/journal.pone.0034117.g003
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the observed one within the matrix (Fig. 6B3). In this case, like in
muscle implantation model, fatty tissue and red blood cells are also
but barely appreciable, being bone most of the formed tissue.
These results in rabbit models indicate that material on its own
conducts surrounding tissue and allow cell ingrowth, thanks to the
scaffold structure. In addition, scaffolds with BMP-2 show also
osteoinductive properties.
3.3. Pig Maxillary tissue: Clinically relevant animal
model. In order to extend on the applicability of these
structurally customizable scaffolds, a specific design was
fabricated and pig, which is physiologically closer to human
being, was used as animal model. In odontology lack of enough
bone tissue volume to work is a usual clinical problem. Thus,
critical size superior maxillary defects was used as model of poor
bone tissue volume area. Robocast/BMP-2 scaffold was tested as
bone augmentation agent and samples were specifically designed
in order to allow their immobilization by two screws. With
comparative purposes, clinically available conventional porous
ceramic blocks (Bio-OssH) with irregular internal pore structure
were also implanted.
Figure 7A shows specifically designed material and its structural
properties. Surgery is shown in fig. 7B where defect, Robocast
material (which fits to performed defect) and screw implantation
could be observed. Fig. 7C also shows implanted Bio-OssH blocks,
which were mechanically polished in order to fit to the defect area
and which required surgical glue in order to fix them to defects.
Three months after surgery samples were harvested and fig. 8
summarizes obtained results. BMP-2 loaded samples showed high
amount of newly formed bone in the defect area, compared to
empty control and control ceramic scaffolds. Fig. 8 shows it in
images which correspond to performed microCT and histological
studies. Differences in bone volume are appreciable in microCT
images, while histologies show differences in the newly formed
bone structure due to implanted materials. Bone follows material
internal structure and, being robocast structure regular, it could be
observed in histological samples (see fig. 8C4, which correspond to
the centre of a sample, in the area between screws).
The differences shown in figure 8 were measured in 13 from all
16 samples, and obtained microCT data are summarizes in
figure 9. Although some treatments were tested only in duplicate,
data show statistical differences in bone formation between empty
and all other treatments (p#0.05 for control and ceramic scaffolds,
p#0.001 for SFF/BMP-2 and Bio-OssH/BMP-2 scaffolds). No
differences were observed between control Robocast and Bio-OssH
scaffolds and neither between BMP-2 carrier materials. Thus, it
could be concluded that tested Robocast scaffolds have similar
osteoconductive properties to an already clinically available
material (Bio-OssH) and show similar osteoinduction due to
BMP-2 activation. However, SFF ceramic scaffolds could be
Figure 4. ALP activity measurements. Time course plot of ALP
activity in control scaffolds (Control), BMP-2 adsorbed scaffolds (BMP-2)
and Chitosan/BMP-2 coated scaffolds (CH/BMP-2).
doi:10.1371/journal.pone.0034117.g004
Figure 5. Implantation in rabbit muscle. A) control scaffolds, B) BMP-2 adsorbed scaffolds: 1) Hematoxilin/Eosin stainings, 2) Massons tricrome
stainings. Dotted line marks scaffold limits. Empty round spaces correspond to the ceramic material. A1, A2) Fibrous tissue (F) and muscle tissue (M)
are present in the structure of the control scaffolds. B1, B2) Newly formed bone (green tissue: arrows, q), fatty tissue with vessels (asterisks, *) and red
blood cells (arrow heads, .) are observed in BMP-2 adsorbed scaffolds.
doi:10.1371/journal.pone.0034117.g005
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facilitate surgery procedure.
4. Conclusions
SFF designed ceramic scaffolds have the great advantage that
external shape and macroporosity architecture can be precisely
controlled by the spacing of the deposited ink rods. This work
shows the biocompatible and conductive properties of custom-
designed ceramic scaffolds. Osteoinductive properties have been
added via incorporation of BMP-2 in structure. A scaffold was
specifically designed taking into account a clinical problem and
results show the potential applicability of this scaffolding method.
Future work would be directed to study specifically designed
structures and external shapes for specific applications in
odontology, traumatology and bone cancer surgery.
Materials and Methods
1. Ethics Statement
All animal handling and experimental procedures were
approved by the Animal Care and Usage Committee of
Universidad Complutense and Hospital Clı ´nico San Carlos,
according to the guidelines for ethical care of experimental
animals of the European Community.
2. Scaffold fabrication
The preparation of the HA and b-TCP scaffolds can be found
elsewhere [16,18]. Briefly, commercially available ceramic pow-
ders (Fluka, Buchs, Switzerland), with an average particle size of
1.860.8 mm, were used to prepare inks for robocasting. The inks
were used to build scaffolds layer-by-layer with a total of 44, using
Robocad 3.0 (3D Inks, Stillwater, OK, USA) for computer design,
in which the in-plane line spacing (from center to center) of the
rods was set to 400 mm and the layer spacing at 225 mm. A three-
axis robotic arm moved the injection syringe while pressing the
ceramic ink through conical deposition nozzles of 250 mm
diameter, immersed in an oil bath, to create the self-supporting
3-D networks. The resulting samples were dried in air at room
temperature for 24 h and then at 400uC for 1 h to evaporate
organics, followed by a sintering treatment at 1300uC for 2 h.
Then, the scaffolds were cut to 36363 mm pieces. Previously to
the in vitro and in vivo experiments pieces were heat sterilized at
300uC.
3. BMP-2 incorporation on scaffolds
Escherichia-coli-produced recombinant human BMP-2 (rhBMP-2)
was generously supplied by Noricum S.L. (Spain). BMP-2 was
adsorbed onto robocasting surface (500 mg/piece) as described in
previous works for other porous ceramic scaffolds [32,50]. Briefly,
each piece was immersed in 400 mL of a BMP-2 solution
(1.25 mg/mL, 50 mM acetic acid). Then, the samples were
incubated in a sterile laminar flow hood at room temperature. The
absorbance at 280 mm was measured in the remaining adsorption
media, in order to ensure that all the BMP-2 was absorbed on the
scaffold. For pig implantation model, BMP-2 was incorporated to
scaffolds via chitosan/BMP-2 coating (1 mg of BMP-2/piece) as it
has been described elsewhere [40–42].
4. Microcomputed tomography (m-CT)
A mCT system (eXplore Vista, GE) was used to perform non-
destructive imaging and to quantify the 3D microarchitectural
morphology of each sample. Samples were imaged with an X-ray
tube voltage of 50 kV and a current of 200 mA. The scanning
angular rotation was 180u, the angular increment 0.40u, and the
voxel resolution 50 mm. Data sets were reconstructed and
segmented into binary images (8-bit BMP images) for the
subsequent image processing, measurements and 3D surface
Figure 6. Implantation in rabbit bone. Up, images of the surgical
procedure. A) control scaffolds, B) BMP-2 adsorbed scaffolds. 1) Gross
appearance of harvested samples, 2) Representative mCT slides, 3)
Representative histological images (Massons tricrome stainings). Note
in B1 and B2 bone formation outside structure, which covered all the
scaffold. See in A3 and B3 the tissue formed inside structure. Fibrous
tissue is observed as purple-blue while bone is green.
doi:10.1371/journal.pone.0034117.g006
Figure 7. Implantation in pig maxillary defects: materials and
surgery. A) Robocast ceramic design, macroscopical appearance of
scaffold and microscopical detail. B) Images of surgery procedure,
implantation of a Robocast sample and fixation of it with screws. C)
Microscopical image of a Bio-OssH sample, detail of Bio-OssH sample
preparation procedure and Bio-OssH implanted and fixated with
surgical glue (see blue glue between sample and surrounding bone).
doi:10.1371/journal.pone.0034117.g007
Solid Free Form BMP
PLoS ONE | www.plosone.org 6 March 2012 | Volume 7 | Issue 3 | e34117reconstructions using MicroView ABA 2.2 software (GE Health-
care).
5. Scanning electron microscopy (SEM)
The samples were gold-sputtered (Pelco 91000 sputter coater). A
scanning electron microscope (SEM, JSM-6330F Jeol, Japan) was
used to characterize the surface topography of samples.
6. Cell culture
C2C12 mouse muscle myoblastic cell line was used (CRL
1772, ATTC, USA). Cells were cultured in DMEM high in
glucose (31966-021,GIBCO, UK), containing 10% Fetal Bovine
Serum (10500-064, GIBCO, UK) plus antibiotics (100 U/ml
penicillin and 100 mg/ml streptomycin sulphate) (GIBCO,UK).
Culture conditions were 37uC in a humidified 5% CO2
Figure 8. Implantation in pig maxillary defects: Results. A) Control empty sample. B) Bio-Oss/BMP-2 sample. C) Robocast/BMP-2 sample. 1) 3D
reconstruction of mCT studies. Red arrows indicate bone height. 2) Representative mCT slices. Dotted lines indicate scaffold location. 3) Macroscopic
appearance of histological samples. Dotted lines indicate scaffold location. Squares indicate the area observed in provided histological details (4).
doi:10.1371/journal.pone.0034117.g008
Figure 9. Implantation in pig maxillary defects: Data. Table summarized data obtained from mCT studies (SFF, Robocast scaffolds; BIO, Bio-
Oss). Graphic represent ‘‘Bone Volume’’ and ‘‘Bone Mineral Content’’ (BMC). Data in graphics are provided in mean and standard deviation.
Significative differences stand for: * (p#0.05), ** (p#0.01), *** (p#0.001).
doi:10.1371/journal.pone.0034117.g009
Solid Free Form BMP
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confluence.
7. General set up for all cellular assays
Each sterile scaffold was placed into a well of 48-well plates, and
trypsinized cells were seeded (50000 cells/sample). Afterwards,
400 ml of pre-warmed complete culture medium was added on
each well. Before any measurement, each scaffold was transferred
to a new culture well to avoid contaminations into the results by
cells adhered onto the plastic surface of the well. All assays were
done at least in triplicate.
7.1. Cellular viability assay. Cellular viability was tested
after three days of culture with the calcein AM assay (Molecular
Probes, Eugene, Oregon, USA) as described by the manufacturer.
Briefly, cell culture medium was replaced with 400 mL of PBS-
calcein AM (1 mg/mL). Cells were them incubated 15 minutes at
37uC. Fluorescent images were obtained in an Olympus BX51
microscope.
7.2. Cellular morphology study. Cell cultured scaffolds
were fixed with Formaldehyde 3.7%. For cellular observation with
SEM (JEOL JSM-35 CF), some samples were fixed with
Formaldehyde 3.7%, dehydrated in an alcohol gradient and
prepared by gold-coating using a sputter coater (Pelco 91000). For
confocal microscopy, other samples were also fixed with
Formaldehyde 3.7%. In these samples F-actin was labelled with
Texas Red-Phalloidin (Molecular Probes, Eugene, Oregon, USA)
and nucleus was stained with Hoechst (Molecular Probes, Eugene,
Oregon, USA) as described by the manufacturer. Briefly,
Formaldehyde solution was removed and samples were washed
twice with PBS. Then they were incubated with 0.1% Triton X-
100 in PBS during 5 minutes and washed again with PBS. Finally
samples were incubated with the inmunostaining solution
30 minutes and washed twice with PBS. Images were obtained
and analyzed using Leica Lite software.
7.3. Magnetic resonance imaging (MRI). Both control and
cell-seeded scaffolds were transferred to 1.5 mL tubes and
visualized by MRI. Data was acquired using a 4.7 Tesla Bruker
BIOSPEC 47/40 MRI system with a gradient intensity of 45 G/
cm. A Bruker designed volume coil was used for data acquisition
(diameter=3.5 cm). 2D proton-weighted fast spin echo (FSE) MR
images were acquired with the following settings: repetition time
(TR)=3000 ms; Echo time (TE)=20 ms; slice
thickness=1.5 mm; field of view (FOV)=161c m
2;
matrix=2566256. The resulting resolution was 39 mm639 mm.
3D proton-weighted FSE-MR images were also acquired with the
following settings: TR=3000 ms; TE=20 ms;
FOV=16161c m
2; matrix=25661926192. These data was
reconstructed to yield a reconstructed matrix size of
25662566256, with a resolution of 39 mm656 mm656 mm.
7.4. MTS cell proliferation assay. It was performed as
described by the manufacturer (Aqueous MTS Non-Radioactive
Cell Proliferation Assay, Promega, Madison, WI, USA). Briefly,
scaffolds were transferred to new wells, reconstituted MTS was
added (40 ml MTS in 400 ml medium) and scaffolds were
incubated at 37uC for 90 min. The medium was transferred to
new wells to measure the absorbance (460 nm, Biotek FL-600) and
blank readouts were subtracted. The data obtained were
converted to cell number by interpolation on a standard curve.
7.5. Alamar Blue cell proliferation assay. It was
performed as described by the manufacturer (Biosource,
Camarillo, CA, USA). Briefly, before each measurement
scaffolds were transferred to new wells and new culture medium
and Alamar Blue reagent were added (40 ml of reagent in 400 mlo f
medium). After the incubation period (37uC, 120 min.) the
medium was transferred to new wells, the absorbance (590 nm)
was measured (Biotek FL-600) and blank readouts were
subtracted. The data obtained were converted to cell number by
interpolation on standard curve.
7.6 In vitro testing of BMP-2 activity. The effect of the
scaffold-adsorbed protein was evaluated through the colorimetric
measurement of alkaline phosphatase (ALP) activity. Briefly
described, after the removal of culture medium, scaffolds were
washed with PBS (200 mL). Afterwards, a 100 mL/well of lysis
buffer (50 mM Tris pH 6.8, 0.1% Triton X-100, 2 mM MgCl2)
was added. 10 mL samples were assayed for alkaline phosphatase
activity in 96-well plates, using p-nitrophenylphosphate in 2-
amino-2-methyl-1-propanol buffer as a substrate in a total volume
of 100 mL; after 10 min. at 37uC. The reaction was stopped with
100 mL of 0.5 M NaOH and the absorbance was measured at
450 nm on a Microplate Reader (Biotek FL-600).
8. Experimental in animals (rabbit models)
The in vivo studies were performed in New Zealand male
rabbits, which had an average weight of 3 kg. The rabbits were
anesthetized by intramuscular injection of 2% Rompun (Xylacine
1 mL/10 kg, Bayer) and Imalgene 1000 (ketamine 20 mg/kg,
Merial). Then, the surgical area was shaved and washed with an
antiseptic solution (Betadine, 10% povidone-iodine, Meda Man-
ufacturing, France). For muscle implantation, an incision was
made in the dorsal muscle tissue, samples were inserted (control
samples (n=6) and BMP-2 carrier samples (n=6)). For bone
implantation, an incision was made in the periostium of the tibial
plateau. Later a defect was drilled and a sample was inserted in the
defect (control samples in the right legs (n=5) and BMP-2 carrier
samples in the left legs (n=5)). In all cases wound was sutured
layer-by-layer. Animals were sacrificed after three weeks and
samples were dissected and fixed in formalin solution for
subsequent studies.
9. Experimental in animals (pig model)
Pigs (n=8) were anesthetized with a mixture of Medetomidin
(0.03 mg/kg of DomtorH, Pfizer, Dublin, Ireland), ketamine
(10 mg/kg of KetolarH, Pfizer) and atropin sulfate (0.02 mg/kg
Atropina BraunH, Braun Surgical SA, Rubı ´, Barcelona, Spain)
delivered by intramuscular injection. During the surgery the
animals were monitorized and anaesthesia was maintained with
Propofol 1%. 2 defects were created in each pig. In each case, the
gingiva was open and palatal flap was elevated. From distal to
palatal, and below the root of the teeth, a critical size defect was
created (1.5 cm61c m 61 cm) and a scaffold was inserted in the
defect. The SFF implants (1.5 cm60.9 cm60.9 cm) were fixed
with 2 screws. Bio-OssH samples were cut to fit to defect area and
fixed with surgery glue (histoacrylH surgical glue, Braun Surgical,
Tuttlingen, Germany). After surgery, daily during seven days, the
animals received Amoxicilin (7 mg/10 kg) and clavulamic acid
(1.75 mg/19 kg of SyinuloxH, Pfizer) by intramuscular injection.
Pigs were euthanized 3 months after surgery by intravenous
injection of 100 mg/kg of sodium pentobarbital. Samples were
harvested and screws were removed for mCT and histological
evaluation.
9.1. 3D imaging and sample measurements. Before the
histological analysis 13 from all 16 samples were observed by
microcomputed tomography (m-CT) as described above (see 4.3.).
All measurements and 3D surface reconstructions were performed
with MicroView ABA 2.2 software (GE Healthcare). Mean and
standard deviation were obtained from ‘‘Bone Volume’’ and
‘‘Bone Mineral Content’’ parameters. Statistical analysis was
performed using GraphPad Prism version 5.00 for Windows,
Solid Free Form BMP
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ANOVA Analysis with Dunnet post-test between all treatments
and control (empty defect) was performed. Significative differences
stands for: * (p#0.05), ** (p#0.01), *** (p#0.001).
9.2. Histology. Samples were decalcified with 10% nitric
acid during 3 days. After dehydration, decalcified samples were
paraffin-embedded and longitudinally sectioned for histological
study. Three different serial slices were obtained in each sample
(10 slices in each series). Hematoxylin and eosin and Masson’s
tricrome stainings were performed. The histological processing
was performed by Dominion-Pharmakine histology services (www.
pharmakine.com). Stained slides were viewed with an Olympus
BX51 microscope.
Supporting Information
Movie S1 3D MRI study. Video shows the 3D reconstruction
of an entire scaffold. Brightness corresponds to seeded cells which
colonize all structure.
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